ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Relief for IBS, Colitis, Crohn’s And More

B Vitamins May Protect Against Damaging Effects of Air Pollution, and Improve Cognition and Psychiat...

Restless Leg Syndrome (RLS) - are you running a marathon each night?

Can Magnesium Relieve Your Tinnitus?

Resveratrol Proven to Slow Brain Aging

Cassia Bark Oil: Why It's Valuable in Traditional Chinese Medicine

Fruits and vegetables' latest superpower? Lowering blood pressure

Neroli Oil: The Pleasantly Fragrant Citrus Oil

Prenatal vitamin D could help prevent autism in children

Magnesium Protects Against Stroke, Heart Disease and Diabetes

 
Print Page
Email Article

New Research Suggests Method for Pre-symptomatic Diagnosis of Dementias

  [ Not Yet Rated ]   [ Discuss This Article ]
By Press Release of National Institute on Aging • www.ProHealth.com • August 1, 1997


A research study at the National Institute on Aging (NIA) suggests that a new method using brain scans may detect brain changes predictive of dementia before memory loss begins. If this or other methods prove effective in larger scale testing, then research could be directed at developing drugs to help arrest or slow the disease process before significant damage is done to the brain.
The research is reported in the August, 1997 issue of The American Journal of Psychiatry (Pietrini P et al, "Low Glucose Metabolism During Brain Stimulation in Older Down's Syndrome Subjects at Risk for Alzheimer's Disease Prior to Dementia", Am J. Psychiatry, 154:8, 1997). and was conducted by a team of NIA scientists headed by Pietro Pietrini, M.D. Ph.D., and Mark B. Schapiro, M.D. . The researchers studied volunteers with Down's syndrome because most patients exhibit neuropathology similar to that of Alzheimer's disease after middle age and develop many cognitive defects similar to those in Alzheimer's disease later in life.
In order to test whether development of an Alzheimer's-like dementia could be predicted well before the onset of any outward mental or physical signs, the researchers chose 16 healthy Down's syndrome adults. They divided the patients into a younger group between the ages of 32 to 38 and an older group between the ages 43 to 61 which might be expected to be developing early Alzheimer's-like pathology. By using positron emission tomography (PET), the scientists were able to observe brain activity while the subjects were at rest (wearing earplugs and blindfolds) or while their brains were stimulated by viewing a movie. In order to assure their comfort and ease, we monitored these patients' anxiety levels during PET testing. Variations in activity in specific regions of brain in the PET scans showed researchers where there were low activity levels, which are associated with early Alzheimer's disease.
According to Dr. Pietrini, "although persons with Down's do not develop dementia at the same ages as persons who develop Alzheimer's disease, they comprise an excellent group for study because of the high incidence rate for Alzheimer's-like dementia in this population. I believe we have identified evidence of dementia at a much earlier stage than previously described by other investigators. We saw no difference in resting brain activity but when we looked at stimulated brain activity, we were able to see decreases in our older group of patients in areas of the brain that we know show Alzheimer's-like tissue changes." Dr. Schapiro adds, "The subjects in the present study were all healthy and exhibited no outward signs of dementia. The inability of this group to respond normally to visual stimulation indicates that the disease process leads to changes in brain function even sooner than we expected. We also found that in this older group, during stimulation, the left side of the brain seemed to be more impaired than the right, suggesting that the left side of the brain may be preferentially affected early in the disease process. As an interesting unexpected observation, cognitive function that was not related to memory was not impaired, suggesting some plasticity, which is the ability of the brain to compensate for metabolic impairments during the stimulation activity."
According to Dr. Pietrini, "It must be pointed out, however, that this study was done on a small group of persons with Down's and must be replicated on a much larger scale and in other people at risk for Alzheimer's before actual testing of interventions using this procedure could be advised or planned. Studies that specifically identified persons in the pre-symptomatic stages of Alzheimer's would give us early clues as to the promise of actual interventions that could be put into practice in years to come."
Alzheimer's disease affects 4 million Americans and that number is expected to increase several-fold as more people live longer. Prevention or treatment of the disease is thus of great practical importance, and as has been learned in many human diseases, the earlier one can intervene in the disease process, the greater the likelihood for a positive long-term outcome.
Other investigators who took part in the study from the NIA are Alessio Dani, M.D., Maura Furey, Ph.D., Gene E. Alexander, Ph.D., Ulderico Freo, M.D., Cheryl L. Grady, Ph.D., Marc J. Mentis, M.D., David Mangot, B.S., Elliot W. Simon, Ph.D., Barry Horwitz, Ph.D., and James V. Haxby, Ph.D.


Source: National Institute on Aging
Press Release
August 1, 19



Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Optimized Curcumin Longvida® Ultra ATP+, Double Strength

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Breakthrough Form of Magnesium Enhances Memory and Cognitive Function Breakthrough Form of Magnesium Enhances Memory and Cognitive Function
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health
Complete and Natural Menopause Relief Complete and Natural Menopause Relief
Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?
Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map